RecruitingNot ApplicableNCT06896032
Retro-walking Versus Forward-walking Training Using Underwater Treadmill in Patients With Knee Osteoarthritis
Effect of Retro-walking Versus Forward-walking Training Using Underwater Treadmill on Pain and Function in Patients With Knee Osteoarthritis
Sponsor
Nourhan Atwa Said
Enrollment
60 participants
Start Date
Mar 30, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study Will investigate and compare the effects of retro-walking and forward-walking underwater treadmill training on pain, function and ROM in subjects with chronic knee OA
Eligibility
Min Age: 40 YearsMax Age: 60 Years
Inclusion Criteria5
- patients with chronic knee OA.
- Age ranges from 40-60 years old of both genders.
- body mass index (BMI) 25- 35kg/m2.
- The degree of osteoarthritis was mild or moderate and have a Kellgren- Lawrence radiographic grade of of1-3.
- unilateral knee osteoarthritis involvement.
Exclusion Criteria10
- hydrophobia.
- pregnancy.
- infection.
- psychiatric disorder.
- haemorrhagic diathesis.
- cardiac pacemaker.
- all Subjects with deformity of hip, knee \& ankle.
- any CNS or PNS involvement.
- recent steroidal or intraarticular injections (3 months).
- systemic inflammatory disease and bone malignancy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERphysical therapy intervention
retro-walking and forward-walking underwater treadmill training
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06896032
Related Trials
Dose Response of Exercise for Arthritis Management
NCT068806531 location
Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.
NCT069028051 location
Arthrosemid vs. Steroid for the Management Knee Osteoarthritis
NCT074895211 location
Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis
NCT074048911 location
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
NCT0715347194 locations